TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

BEXIMCO PHARMS USA

DermatologyInfectious Disease
Generics

BEXIMCO PHARMS USA is a generic drug manufacturer focused on Dermatology, Infectious Disease.

1991
Since
2
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 50%
1 drugs
Infectious Disease 50%
1 drugs

Pipeline Strength Pro

Loading...